EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeitOpen Access · CC BY 4.0

Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic–Ischaemic Encephalopathy: A Systematic Review

Dario Colacurci iD, Laura Sarno iD, Emmanuel Fiore, Francesco Raimondi, Nina Martinelli, Angelo Sirico iD, Costantino Di Carlo, Giuseppe Bifulco, Maurizio Guida, Giuseppe Maria Maruotti

Genes · 24.07.2026 · 17 (8) · 862

DOI: 10.3390/genes17080862 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Genes, online erschienen am 24.07.2026. Verfasst von Dario Colacurci und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Brain Diseases. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal encephalopathy (NE) is a major cause of neonatal mortality and long-term neurological disability. Although hypoxic–ischaemic encephalopathy (HIE) is the most common cause, several genetic disorders may mimic or coexist with hypoxic–ischaemic injury. Next-generation sequencing has emerged as a promising diagnostic tool in this setting. This systematic review evaluated the current evidence on genomic sequencing in NE. Material and methods: A systematic review was conducted according to PRISMA 2020 guidelines and prospectively registered in PROSPERO. PubMed/MEDLINE, Embase, and Scopus were searched from inception to June 2026. Eligible studies included neonates (≤28 days) with NE, suspected or confirmed HIE, HIE mimics, or unexplained NE who underwent genomic sequencing. Whole-exome sequencing (WES), whole-genome sequencing (WGS), clinical exome sequencing (CES), rapid genomic sequencing, and targeted next-generation sequencing panels were considered. Study quality was assessed using the Newcastle–Ottawa Scale.

Results

Seven studies met the inclusion criteria. Considerable heterogeneity was observed regarding patient selection, sequencing strategies, and reported outcomes. Among diagnostic sequencing studies, diagnostic yield ranged from 23.5% to 53.1%. Pathogenic and likely pathogenic variants were identified in genes associated with developmental and epileptic encephalopathies, metabolic disorders, mitochondrial diseases, and neurodevelopmental syndromes, including SCN2A, KCNQ2, CACNA1A, STXBP1, PTPN11, BCOR, MMUT, COQ2, and GBE1. Genomic sequencing frequently refined or changed the initial diagnosis, improved prognostic assessment and genetic counselling, and, in selected cases, guided disease-specific treatment. One study investigated genetic susceptibility to hypoxic–ischaemic injury rather than diagnostic sequencing.

Conclusions

Genomic sequencing provides clinically meaningful diagnoses in a substantial proportion of neonates with unexplained NE or atypical HIE presentations. Current evidence supports integrating genomic sequencing into the diagnostic evaluation of selected infants, although larger prospective studies are needed to define its optimal timing, clinical utility, and cost-effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoxia-Ischemia, BrainBrain DiseasesHumansInfant, NewbornHigh-Throughput Nucleotide SequencingExome Sequencing

Stichwörter der Autor:innen

genetic diagnosishypoxic–ischaemic encephalopathyneonatal encephalopathyneonatal seizuresprecision medicinewhole-exome sequencing

Autor:innen und Institutionen

  • Department of Public Health, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.
  • Department of Neurosciences, Reproductive Science and Dentistry, University of Naples Federico II, via Pansini 5, 80131 Naples, Italy.
  • Mother and Child Department, University Hospital Federico II, via Pansini 5, 80131 Naples, Italy.
  • Division of Neonatology, Department of Translational Medical Sciences, Federico II University, via Pansini 5, 80131 Naples, Italy.
  • Department of Woman, Child and General and Specialized Surgery, University of Campania "Luigi Vanvitelli", via Armanni 14, 80138 Naples, Italy.

ORCID-Profile: Dario Colacurci, Laura Sarno, Angelo Sirico

Zitieren

APA

Colacurci, D., Sarno, L., Fiore, E., Raimondi, F., Martinelli, N., Sirico, A., Di Carlo, C., Bifulco, G., Guida, M., & Maruotti, G. M. (2026). Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic–Ischaemic Encephalopathy: A Systematic Review. Genes, 17(8), 862. https://doi.org/10.3390/genes17080862

Vancouver

Colacurci D, Sarno L, Fiore E, Raimondi F, Martinelli N, Sirico A, et al. Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic–Ischaemic Encephalopathy: A Systematic Review. Genes. 2026;17(8):862. doi:10.3390/genes17080862

BibTeX
@article{Colacurci2026,
  author = {Colacurci, Dario and Sarno, Laura and Fiore, Emmanuel and Raimondi, Francesco and Martinelli, Nina and Sirico, Angelo and Di Carlo, Costantino and Bifulco, Giuseppe and Guida, Maurizio and Maruotti, Giuseppe Maria},
  title = {Genomic Sequencing in Neonatal Encephalopathy and Suspected Hypoxic–Ischaemic Encephalopathy: A Systematic Review},
  journal = {Genes},
  year = {2026},
  volume = {17},
  number = {8},
  pages = {862},
  doi = {10.3390/genes17080862}
}
Kostenlos starten →